.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Harvard Business School
UBS
Accenture
Dow
Mallinckrodt
Citi
US Army
Baxter
Cantor Fitzgerald

Generated: July 24, 2017

DrugPatentWatch Database Preview

SELENOMETHIONINE SE 75 Drug Profile

« Back to Dashboard

What is the patent landscape for Selenomethionine Se 75, and what generic Selenomethionine Se 75 alternatives are available?

Selenomethionine Se 75 is a drug marketed by Pharmalucence, Ge Healthcare, and Mallinckrodt. and is included in three NDAs.

The generic ingredient in SELENOMETHIONINE SE 75 is selenomethionine se-75. There is one drug master file entry for this compound. Additional details are available on the selenomethionine se-75 profile page.

Summary for Tradename: SELENOMETHIONINE SE 75

Patents:0
Applicants:3
NDAs:3
Bulk Api Vendors: see list52
Clinical Trials: see list9
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SELENOMETHIONINE SE 75 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmalucence
SELENOMETHIONINE SE 75
selenomethionine se-75
INJECTABLE;INJECTION017322-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ge Healthcare
SELENOMETHIONINE SE 75
selenomethionine se-75
INJECTABLE;INJECTION017257-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mallinckrodt
SELENOMETHIONINE SE 75
selenomethionine se-75
INJECTABLE;INJECTION017098-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Cipla
McKesson
Teva
Baxter
Chinese Patent Office
Mallinckrodt
Cerilliant
Federal Trade Commission
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot